Retraction Volume 15, Issue 3 pp 881
Retraction: LncRNA AK045171 protects the heart from cardiac hypertrophy by regulating the SP1/MG53 signalling pathway
- 1 Heart Center and Beijing Key Laboratory of Hypertension, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China
Received: April 27, 2020 Accepted: December 24, 2022 Published: February 15, 2023
https://doi.org/10.18632/aging.204530How to Cite
Copyright © 2023 Xu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This article has been retracted: Aging has completed its investigation of this paper. The investigation found that the text and figures overlap with an article by different authors published in another journal [1], which has already been retracted. The Figure 1C “sham” image is identical with “TAC” image in Figure 2C from the Aging paper and the Figure 2E “TAC” image from the aforementioned other paper [1]. Two additional panels of Figure 2C also are identical to two panels of Figure 2E in the other paper [1]. Figure 2B - H&E staining of the heart tissue - bottom panels “TAC” and “TAC+Ad-AK045171” are identical with the bottom “TAC” and “sham” images of Figure 4F of the other paper [1]. The authors informed the journal that they have agreed with the retraction.
The Administration of the Beijing Chaoyang Hospital, Capital Medical University was notified about the retraction by Aging Journal.
References
- 1. Wang W, Liu N, Xin L, Ruan Y, Du X, Bai R, Dong J, Ma C. RETRACTED ARTICLE: inhibition of miR-296-5p protects the heart from cardiac hypertrophy by targeting CACNG6. Gene Ther. 2021; 28:391. https://doi.org/10.1038/s41434-019-0109-0 [PubMed]